ÌÇÐÄÆƽâ°æ

Forecast of leading pharmaceutical companies based on global oncology sales in 2030 (in billion U.S. dollars)

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

July 2024

Region

Worldwide

Survey time period

as of May 2024

Supplementary notes

All values are forecasts.

Citation formats

Global top 5 companies by forecasted oncology sales 2030

Published by A. Minhas, Sep 9, 2024

The top five pharmaceutical companies based on projected global oncology revenue in 2030 include Johnson & Johnson, AstraZeneca, and Roche, to name a few. Roche’s oncology products are expected to generate some ** billion U.S. dollars in that year.

Oncology pharmaceuticals

Among U.S. oncology brands in 2023, Merck’s Keytruda was the top revenue generating oncology brand. Also, globally, Keytruda was the top oncology product in 2023. There are many new cancer drugs in development. Drugs against cancer are by far the largest therapeutic group of products in the R&D pipeline worldwide.

Cancer prevalence and treatments

The U.S. and leading EU countries had the highest prevalence of diagnosed cancer cases globally as of 2019. Among all types of cancer, trachea, bronchus and lung cancer are the deadliest, followed by liver cancer. The availability of cancer treatments varies around the world. The U.S. and Germany had the largest number of new medications for cancer available.

Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Oncology "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Oncology

Cancer facts

5

Oncology market

6

Cancer drugs

3

Companies

6

Research and development

5

Immuno-oncology

5

Treatment types

5

Physicians and patients

8

Further Content: You might find this interesting as well

Topics

AstraZenecaGlobal pharmaceutical industryPharmaceutical industry in the U.S.NovartisMerck & Co.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.